{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T10:38:45Z","timestamp":1783247925911,"version":"3.54.6"},"reference-count":35,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1111\/ane.13025","type":"journal-article","created":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T13:10:38Z","timestamp":1536412238000},"page":"33-41","source":"Crossref","is-referenced-by-count":79,"title":["Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis"],"prefix":"10.1155","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8748-0083","authenticated-orcid":false,"given":"Simona","family":"Lattanzi","sequence":"first","affiliation":[{"name":"Neurological Clinic, Department of Experimental and Clinical Medicine; Marche Polytechnic University; Ancona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2416-147X","authenticated-orcid":false,"given":"Gaetano","family":"Zaccara","sequence":"additional","affiliation":[{"name":"Department of Medicine, Unit of Neurology; Florence Health Authority; Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Giovannelli","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Psychology, Drug Research, Child Health; University of Florence; Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Grillo","sequence":"additional","affiliation":[{"name":"Medical Department Eisai s.r.l; San Donato Milanese Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Nardone","sequence":"additional","affiliation":[{"name":"Department of Neurology; \u201cFranz Tappeiner\u201d Hospital; Merano Italy"},{"name":"Department of Neurology; Christian Doppler Klinik, Paracelsus Medical University; Salzburg Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Silvestrini","sequence":"additional","affiliation":[{"name":"Neurological Clinic, Department of Experimental and Clinical Medicine; Marche Polytechnic University; Ancona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Trinka","sequence":"additional","affiliation":[{"name":"Department of Neurology; Christian Doppler Klinik, Paracelsus Medical University; Salzburg Austria"},{"name":"Center for Cognitive Neuroscience; Salzburg Austria"},{"name":"Public Health, Health Services Research and HTA; University for Health Sciences, Medical Informatics and Technology; Hall i.T Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0928-1577","authenticated-orcid":false,"given":"Francesco","family":"Brigo","sequence":"additional","affiliation":[{"name":"Department of Neurology; \u201cFranz Tappeiner\u201d Hospital; Merano Italy"},{"name":"Department of Neuroscience, Biomedicine and Movement Science; University of Verona; Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"key":"10.1111\/ane.13025-BIB0001|ane13025-cit-0001","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/01.wnl.0000252807.38124.a3","article-title":"How common are the \u201ccommon\u201d neurologic disorders?","volume":"68","author":"Hirtz","year":"2007","journal-title":"Neurology"},{"key":"10.1111\/ane.13025-BIB0002|ane13025-cit-0002","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1212\/WNL.0000000000000619","article-title":"Seizure course during pregnancy in catamenial epilepsy","volume":"83","author":"Cagnetti","year":"2014","journal-title":"Neurology"},{"key":"10.1111\/ane.13025-BIB0003|ane13025-cit-0003","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.03.003","article-title":"The descriptive epidemiology of epilepsy-a review","volume":"85","author":"Banerjee","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.13025-BIB0004|ane13025-cit-0004","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/j.1528-1167.2010.02589.x","article-title":"When clinical trials make history: demonstrating efficacy of new antiepileptic drugs as monotherapy","volume":"51","author":"Perucca","year":"2010","journal-title":"Epilepsia"},{"key":"10.1111\/ane.13025-BIB0005|ane13025-cit-0005","unstructured":"European Medicines Agency Guideline on clinical investigation of medicinal products in the treatment of epileptic disorders 2010 https:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2010\/01\/WC500070043.pdf"},{"key":"10.1111\/ane.13025-BIB0006|ane13025-cit-0006","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","article-title":"Subcommission on AED Guidelines. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"issue":"7","key":"10.1111\/ane.13025-BIB0007|ane13025-cit-0007","first-page":"CD001904","article-title":"Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review","author":"Nolan","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1111\/ane.13025-BIB0008|ane13025-cit-0008","first-page":"CD001911","article-title":"Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review","author":"Nolan","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1111\/ane.13025-BIB0009|ane13025-cit-0009","first-page":"CD001031","article-title":"Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review","author":"Nolan","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/ane.13025-BIB0010|ane13025-cit-0010","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1474-4422(11)70154-5","article-title":"Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial","volume":"10","author":"Kwan","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.13025-BIB0011|ane13025-cit-0011","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/0962280207080643","article-title":"Evaluation of networks of randomized trials","volume":"17","author":"Salanti","year":"2008","journal-title":"Stat Methods Med Res"},{"key":"10.1111\/ane.13025-BIB0012|ane13025-cit-0012","doi-asserted-by":"crossref","first-page":"j3932","DOI":"10.1136\/bmj.j3932","article-title":"Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples","volume":"358","author":"Riley","year":"2017","journal-title":"BMJ"},{"key":"10.1111\/ane.13025-BIB0013|ane13025-cit-0013","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1111\/ane.13025-BIB0014|ane13025-cit-0014","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] Higgins JPT Green S 2011 https:\/\/handbook-5-1.cochrane.org\/"},{"key":"10.1111\/ane.13025-BIB0015|ane13025-cit-0015","unstructured":"ICWG Report of the Indirect Comparisons Working Group to the Pharmaceutical Benefits Advisory Committee: assessing indirect comparisons 2009 https:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/"},{"key":"10.1111\/ane.13025-BIB0016|ane13025-cit-0016","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0272989X12458724","article-title":"Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Making"},{"key":"10.1111\/ane.13025-BIB0017|ane13025-cit-0017","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/01.wnl.0000252941.50833.4a","article-title":"Levetiracetam Monotherapy Study Group. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy","volume":"68","author":"Brodie","year":"2007","journal-title":"Neurology"},{"key":"10.1111\/ane.13025-BIB0018|ane13025-cit-0018","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1474-4422(12)70105-9","article-title":"Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial","volume":"11","author":"Baulac","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.13025-BIB0019|ane13025-cit-0019","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(16)30292-7","article-title":"Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non inferiority trial","volume":"16","author":"Baulac","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.13025-BIB0020|ane13025-cit-0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/epi.13993","article-title":"Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study","volume":"59","author":"Trinka","year":"2018","journal-title":"Epilepsia"},{"key":"10.1111\/ane.13025-BIB0021|ane13025-cit-0021","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1046\/j.1528-1157.2001.04501.x","article-title":"Effectiveness of first antiepileptic drug","volume":"42","author":"Kwan","year":"2001","journal-title":"Epilepsia"},{"key":"10.1111\/ane.13025-BIB0022|ane13025-cit-0022","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/ane.12803","article-title":"Eslicarbazepine acetate as adjunctive treatment in partial-onset epilepsy","volume":"137","author":"Lattanzi","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.13025-BIB0023|ane13025-cit-0023","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/jnnp-2011-300376","article-title":"KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy","volume":"84","author":"Trinka","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.13025-BIB0024|ane13025-cit-0024","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"Study group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/ane.13025-BIB0025|ane13025-cit-0025","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/bmj.326.7387.472","article-title":"Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses","volume":"326","author":"Song","year":"2003","journal-title":"BMJ"},{"issue":"11 Suppl. 4","key":"10.1111\/ane.13025-BIB0026|ane13025-cit-0026","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.60.11_suppl_4.S2","article-title":"Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy","volume":"60","author":"Kwan","year":"2003","journal-title":"Neurology"},{"key":"10.1111\/ane.13025-BIB0027|ane13025-cit-0027","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1059-1311(03)00047-5","article-title":"Measuring the efficacy of antiepileptic drugs","volume":"12","author":"Mohanraj","year":"2003","journal-title":"Seizure"},{"key":"10.1111\/ane.13025-BIB0028|ane13025-cit-0028","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1007\/s00415-015-8018-7","article-title":"Analysis of nocebo effects of antiepileptic drugs across different conditions","volume":"263","author":"Zaccara","year":"2016","journal-title":"J Neurol"},{"key":"10.1111\/ane.13025-BIB0029|ane13025-cit-0029","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.seizure.2015.03.003","article-title":"Lacosamide monotherapy for partial onset seizures","volume":"27","author":"Lattanzi","year":"2015","journal-title":"Seizure"},{"key":"10.1111\/ane.13025-BIB0030|ane13025-cit-0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/CE.S142858","article-title":"Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy. An evidence based review of efficacy, safety and place in therapy","volume":"13","author":"Lattanzi","year":"2018","journal-title":"Core Evidence"},{"key":"10.1111\/ane.13025-BIB0031|ane13025-cit-0031","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1684\/epd.2012.0511","article-title":"What clinical trial designs have been used to test antiepileptic drugs and do we need to change them?","volume":"14","author":"Perucca","year":"2012","journal-title":"Epileptic Disord"},{"key":"10.1111\/ane.13025-BIB0032|ane13025-cit-0032","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/epi.14035","article-title":"Comparing the dosages of lacosamide, eslicarbazepine acetate, and controlled-release carbamazepine in noninferiority epilepsy monotherapy trials: How much \u201cfair\u201d is \u201cfair\u201d?","volume":"59","author":"Brigo","year":"2018","journal-title":"Epilepsia"},{"key":"10.1111\/ane.13025-BIB0033|ane13025-cit-0033","first-page":"MR000007","article-title":"Individual participant data meta-analyses compared with meta-analyses based on aggregate data","volume":"9","author":"Tudur Smith","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1111\/ane.13025-BIB0034|ane13025-cit-0034","first-page":"CD011412","article-title":"Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data","volume":"2017","author":"Nevitt","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/ane.13025-BIB0035|ane13025-cit-0035","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1212\/WNL.57.9.1536","article-title":"Future directions for epilepsy research","volume":"57","author":"Jacobs","year":"2001","journal-title":"Neurology"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.13025","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.13025\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:51:42Z","timestamp":1671540702000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.13025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.13025","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,24]]}}}